BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

S. J. Dawson; N. Makretsov; F. M. Blows; K. E. Driver; E. Provenzano; J. Le Quesne; L. Baglietto; G. Severi; G. G. Giles; C. A. McLean; G. Callagy; A. R. Green; I. Ellis; K. Gelmon; G. Turashvili; S. Leung; S. Aparicio; D. Huntsman; C. Caldas; P. Pharoah

doi:10.1038/sj.bjc.6605921

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

S. J. Dawson, N. Makretsov, F. M. Blows, K. E. Driver, E. Provenzano, J. Le Quesne, L. Baglietto, G. Severi, G. G. Giles, C. A. McLean, G. Callagy, A. R. Green, I. Ellis, K. Gelmon, G. Turashvili, S. Leung, S. Aparicio, D. Huntsman, C. Caldas, P. Pharoah

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Original language	English
Pages (from-to)	1137
Number of pages	1
Journal	British Journal of Cancer
Volume	103
Issue number	7
DOIs	https://doi.org/10.1038/sj.bjc.6605921
Publication status	Published - 28 Sept 2010

Access to Document

10.1038/sj.bjc.6605921

Cite this

Dawson, S. J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., Callagy, G., Green, A. R., Ellis, I., Gelmon, K., Turashvili, G., Leung, S., Aparicio, S., Huntsman, D., Caldas, C., & Pharoah, P. (2010). BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736). British Journal of Cancer, 103(7), 1137. https://doi.org/10.1038/sj.bjc.6605921

@article{44322025fa524592add16c07597a9af4,

title = "BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)",

author = "Dawson, {S. J.} and N. Makretsov and Blows, {F. M.} and Driver, {K. E.} and E. Provenzano and {Le Quesne}, J. and L. Baglietto and G. Severi and Giles, {G. G.} and McLean, {C. A.} and G. Callagy and Green, {A. R.} and I. Ellis and K. Gelmon and G. Turashvili and S. Leung and S. Aparicio and D. Huntsman and C. Caldas and P. Pharoah",

year = "2010",

month = sep,

day = "28",

doi = "10.1038/sj.bjc.6605921",

language = "English",

volume = "103",

pages = "1137",

journal = "British Journal of Cancer",

issn = "0007-0920",

number = "7",

}

Dawson, SJ, Makretsov, N, Blows, FM, Driver, KE, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, GG, McLean, CA, Callagy, G, Green, AR, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C & Pharoah, P 2010, 'BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)', British Journal of Cancer, vol. 103, no. 7, pp. 1137. https://doi.org/10.1038/sj.bjc.6605921

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736). / Dawson, S. J.; Makretsov, N.; Blows, F. M. et al.
In: British Journal of Cancer, Vol. 103, No. 7, 28.09.2010, p. 1137.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - BCL2 in breast cancer

T2 - A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

AU - Dawson, S. J.

AU - Makretsov, N.

AU - Blows, F. M.

AU - Driver, K. E.

AU - Provenzano, E.

AU - Le Quesne, J.

AU - Baglietto, L.

AU - Severi, G.

AU - Giles, G. G.

AU - McLean, C. A.

AU - Callagy, G.

AU - Green, A. R.

AU - Ellis, I.

AU - Gelmon, K.

AU - Turashvili, G.

AU - Leung, S.

AU - Aparicio, S.

AU - Huntsman, D.

AU - Caldas, C.

AU - Pharoah, P.

PY - 2010/9/28

Y1 - 2010/9/28

UR - http://www.scopus.com/inward/record.url?scp=77957221496&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605921

DO - 10.1038/sj.bjc.6605921

M3 - Comment/debate

AN - SCOPUS:77957221496

SN - 0007-0920

VL - 103

SP - 1137

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 7

ER -

BCL2 in breast cancer: A favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (British Journal of Cancer (2010) 103 (668675) Doi:10.1038/sj.bjc.6605736)

Access to Document

Other files and links

Cite this